Tokyo, March 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060930) titled 'Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review' on March 13.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Tokyo University of Pharmacy and Life Sciences
Condition:
Condition - Patients with limited life expectancy and frailty, irrespective of specific diseases.
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the impact of polypharmacy on QOL in frail older adults with limited life expectancy.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key i...